Among all selected prognostic biomarkers, ESR1, PGR, BRTC, YWHAQ and PLK1 were recognized as crucial features; for clinical features, whether the patient has gone through chemotherapy/hormone therapy and the size of the tumor play an important role in model predictions. This evidence concerns the gene PLK1 and neoplasm.